Overview
Michael Kallen is a Hematologist practicing medicine in Baltimore, Maryland.
Dr. Kallen is highly rated in 2 conditions, according to our data. His clinical expertise encompasses Acute Lymphoblastic Leukemia (ALL), Cyclic Neutropenia, Non-Hodgkin Lymphoma, and Acute Myeloid Leukemia (AML).
He is actively involved in clinical research, co-authoring 72 peer reviewed articles and participating in 1 clinical trial.
Specialties
Licenses
Hospital Affiliations
Languages Spoken
Gender
Insurance
Accepted insurance can change. Please verify directly with the provider.
Locations
22 S Greene St, Baltimore, MD 21201
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
1 Clinical Trials
Sidney Kimmel Comprehensive Cancer Center
Dr. Robert Brodsky is a professor of medicine at the Johns Hopkins University School of Medicine. His area of clinical expertise is classical hematology and haploidentical bone marrow transplant for sickle cell disease and aplastic anemia. Dr. Brodsky serves as the director of the Division of Hematology and the T32 Training Program. He is the Johns Hopkins Family Professor of Medicine and Oncology. He received his M.D. from Hahnemann University. He completed his residency at the Vanderbilt University School of Medicine. He performed a fellowship in hematology at the National Institutes of Health and a fellowship in oncology at Johns Hopkins. He joined the Johns Hopkins faculty in 1997. From 2017 to 2022 he served as Associate Editor to The Journal of Clinical Investigation (JCI) and Secretary to American Society of Hematology (ASH). He serves as President of The American Society of Hematology (ASH) in 2023. Dr. Brodsky is highly rated in 26 conditions, according to our data. His clinical expertise encompasses Paroxysmal Nocturnal Hemoglobinuria (PNH), Paroxysmal Cold Hemoglobinuria, Anemia, Bone Marrow Transplant, and Splenectomy. Dr. Brodsky is board certified in American Board Of Internal Medicine. Dr. Brodsky is currently accepting new patients.
Johns Hopkins Hospital
Michael Streiff is a Hematologist practicing medicine in Baltimore, Maryland. Dr. Streiff is highly rated in 35 conditions, according to our data. His clinical expertise encompasses Venous Thromboembolism (VTE), Deep Vein Thrombosis, Pulmonary Embolism, Pancreaticoduodenectomy, and Bone Marrow Aspiration. Dr. Streiff is currently accepting new patients.
Johns Hopkins Bayview Medical Center
Patrick Forde is a Hematologist and an Oncologist practicing medicine in Baltimore, Maryland. Dr. Forde is highly rated in 12 conditions, according to our data. His clinical expertise encompasses Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), Mesothelioma, and Small Cell Lung Cancer (SCLC). Dr. Forde is currently accepting new patients.
Frequently Asked Questions about Dr. Michael E. Kallen
How do I make an appointment with Dr. Michael E. Kallen?
You can book an appointment with Dr. Michael E. Kallen by calling their office at 410-328-1342. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.
Is Dr. Michael E. Kallen a top-rated expert for Acute Lymphoblastic Leukemia (ALL)?
MediFind is an objective health platform that identifies experts based on real-world data. Dr. Michael E. Kallen is classified as an Advanced expert for Acute Lymphoblastic Leukemia (ALL), meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
What conditions does Dr. Michael E. Kallen specialize in?
While Dr. Michael E. Kallen is a Hematology, they have specific expertise in Acute Lymphoblastic Leukemia (ALL), Cyclic Neutropenia, and Non-Hodgkin Lymphoma. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Hematology.
Does Dr. Michael E. Kallen participate in research or clinical trials?
Yes. Dr. Michael E. Kallen has published 72 articles and abstracts on conditions like Acute Lymphoblastic Leukemia (ALL). You can view a list of Dr. Michael E. Kallen's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Advanced
- Acute Lymphoblastic Leukemia (ALL)
- Cyclic NeutropeniaDr. Kallen isAdvanced. Learn about Cyclic Neutropenia.
- Experienced
- Acute Myeloblastic Leukemia with Maturation
- Acute Myeloblastic Leukemia without Maturation
- Acute Myeloid Leukemia (AML)Dr. Kallen isExperienced. Learn about Acute Myeloid Leukemia (AML).
- AgranulocytosisDr. Kallen isExperienced. Learn about Agranulocytosis.
- Aplastic AnemiaDr. Kallen isExperienced. Learn about Aplastic Anemia.
- B-Cell LymphomaDr. Kallen isExperienced. Learn about B-Cell Lymphoma.
- Childhood Acute Myeloid LeukemiaDr. Kallen isExperienced. Learn about Childhood Acute Myeloid Leukemia.
- Diffuse Large B-Cell Lymphoma (DLBCL)Dr. Kallen isExperienced. Learn about Diffuse Large B-Cell Lymphoma (DLBCL).
- Hodgkin LymphomaDr. Kallen isExperienced. Learn about Hodgkin Lymphoma.
- LeukemiaDr. Kallen isExperienced. Learn about Leukemia.
- Multiple MyelomaDr. Kallen isExperienced. Learn about Multiple Myeloma.
- Myelodysplastic Syndrome (MDS)Dr. Kallen isExperienced. Learn about Myelodysplastic Syndrome (MDS).
- Non-Hodgkin LymphomaDr. Kallen isExperienced. Learn about Non-Hodgkin Lymphoma.
- T-Cell LymphomaDr. Kallen isExperienced. Learn about T-Cell Lymphoma.
